Brief: Spectrum Pharmaceuticals Appoints Nora E. Brennan As Chief Financial Officer
11/05/2022 12:04
May 11 (Reuters) - Spectrum Pharmaceuticals Inc SPPI.O :
* SPECTRUM PHARMACEUTICALS APPOINTS NORA E. BRENNAN AS CHIEF
FINANCIAL OFFICER
* APPOINTMENT OF NORA BRENNAN AS CHIEF FINANCIAL OFFICER
EFFECTIVE
MAY 25, 2022
Source text for Eikon: ID:nBw3K6lyMa
Further company coverage: SPPI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Spectrum Pharmaceuticals
See all newsBrief: Assertio Holdings Announces Favorable Vote On Proposed Acquisition Of Spectrum Pharmaceuticals
Brief: Independent Proxy Advisory Firms ISS And Glass Lewis Recommend Spectrum Pharmaceuticals Stockholders Vote “For” Proposed Deal With Assertio Holdings, Inc.
Brief: Spectrum Pharmaceuticals Regains Compliance With Nasdaq Minimum Bid Price Requirement
U.S. RESEARCH ROUNDUP-CTI Biopharma, Park National, Playags
Spectrum Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary